Arteris, Inc. (AIP) VP & counsel reports Form 4 stock transactions

Q: Who is the insider reporting this Form 4 for Arteris (AIP)?

The Form 4 is filed by Paul L. Alpern , who serves as Vice President and General Counsel of Arteris, Inc. , and is reporting his transactions in the company’s common stock.

Q: What stock option exercise did Paul Alpern report for Arteris (AIP)?

On January 5, 2026 , Paul Alpern exercised options covering 2,500 shares of Arteris common stock at an exercise price of $9.28 per share. These options relate to an award of 2,500 options that vest quarterly over 16 quarters starting on April 1, 2025 and expire on February 20, 2035.

Q: How many Arteris (AIP) shares did Paul Alpern sell and at what prices?

Paul Alpern reported selling 2,500 shares of Arteris common stock on January 5, 2026 at $16.00 per share and 4,318 shares on January 6, 2026 at a weighted average price of $16.8913 per share, with individual sale prices ranging from $15.86 to $17.62.

Q: What does the weighted average sale price mean in this Arteris (AIP) Form 4?

The $16.8913 price reported for the January 6, 2026 sale is a weighted average sale price . The shares were sold in multiple transactions at prices between $15.86 and $17.62, and the insider has undertaken to provide detailed per-trade pricing information to the issuer, any security holder, or SEC staff upon request.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Arteris, Inc. VP and General Counsel Paul L. Alpern reported option exercises and stock sales in a Form 4. On January 5, 2026, he exercised options for 2,500 shares of common stock at an exercise price of $9.28 per share, increasing his holdings to 64,468 shares directly owned.

On the same day, he sold 2,500 shares at $16.00, and on January 6, 2026 he sold an additional 4,318 shares at a weighted average price of $16.8913, with actual sale prices ranging from $15.86 to $17.62. After these transactions, he directly owned 57,650 shares of Arteris common stock. The filing notes these trades were made under a Rule 10b5-1 trading plan adopted on June 5, 2025, and that the options for 2,500 shares vest quarterly over 16 quarters starting April 1, 2025 and expire on February 20, 2035.

Insider Trade Summary

Net Seller: 6,818 shares ($112,937)

Net Sell 4 txns

Insider Alpern Paul L

Role VP and General Counsel

Sold 6,818 shs ($113K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,318	$16.8913	$73K
Exercise	Common Stock	2,500	$0.00	--
Exercise	Common Stock	2,500	$9.28	$23K
Sale	Common Stock	2,500	$16.00	$40K

Holdings After Transaction: Common Stock — 57,650 shares (Direct)

Footnotes (1)

Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 5, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.86 to $17.62 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 2,500 shares of options vest quarterly over 16 quarters, with each vesting occurring on the first day of the quarter starting on April 1, 2025.

Form 4 Insider Transactions: What Each Field Means →

01/07/2026 - 06:07 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alpern Paul L

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

95008

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP and General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/05/2026		M⁽¹⁾		2,500	A	$9.28	64,468	D
Common Stock	01/05/2026		S⁽¹⁾		2,500	D	$16	61,968	D
Common Stock	01/06/2026		S⁽¹⁾		4,318	D	$16.8913⁽²⁾	57,650	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	$9.28	01/05/2026		M⁽¹⁾			2,500	⁽³⁾	02/20/2035	Common Stock	2,500	$0.00	0.00	D

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 5, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.86 to $17.62 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. 2,500 shares of options vest quarterly over 16 quarters, with each vesting occurring on the first day of the quarter starting on April 1, 2025.

Remarks:

	/s/ Paul Alpern	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

Who is the insider reporting this Form 4 for Arteris (AIP)?

The Form 4 is filed by Paul L. Alpern, who serves as Vice President and General Counsel of Arteris, Inc., and is reporting his transactions in the company’s common stock.

What stock option exercise did Paul Alpern report for Arteris (AIP)?

On January 5, 2026, Paul Alpern exercised options covering 2,500 shares of Arteris common stock at an exercise price of $9.28 per share. These options relate to an award of 2,500 options that vest quarterly over 16 quarters starting on April 1, 2025 and expire on February 20, 2035.

How many Arteris (AIP) shares did Paul Alpern sell and at what prices?

Paul Alpern reported selling 2,500 shares of Arteris common stock on January 5, 2026 at $16.00 per share and 4,318 shares on January 6, 2026 at a weighted average price of $16.8913 per share, with individual sale prices ranging from $15.86 to $17.62.

How many Arteris (AIP) shares does Paul Alpern own after these transactions?

Following the reported transactions on January 5 and 6, 2026, Paul Alpern directly owns 57,650 shares of Arteris, Inc. common stock.

Were the Arteris (AIP) insider trades made under a Rule 10b5-1 plan?

Yes. The filing states that the transactions were made pursuant to a Rule 10b5-1 trading plan that was adopted by Paul Alpern on June 5, 2025, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

What does the weighted average sale price mean in this Arteris (AIP) Form 4?

The $16.8913 price reported for the January 6, 2026 sale is a weighted average sale price. The shares were sold in multiple transactions at prices between $15.86 and $17.62, and the insider has undertaken to provide detailed per-trade pricing information to the issuer, any security holder, or SEC staff upon request.